1 October 2025 in BULLETIN OF SURGERY IN KAZAKHSTAN
ASAlmaty Syzganov National Scientific Center Of Surgery
Almaty Syzganov National Scientific Center Of Surgery
+3
Today, hepatitis B virus-associated acute liver failure remains the leading cause of liver failure (44% mortality in Asia and 41% in the United States). Studies show that among patients with hepatitis B-associated cirrhosis, acute liver failure develops in 10-20% of cases. Acute liver failure on chronic liver disease is a potentially reversible syndrome that occurs in patients with cirrhosis or chronic liver disease and is characterized by acute decompensation, organ failure, and high short-term mortality. Chronic hepatitis B virus infection is a leading cause of liver morbidity and mortality worldwide. When we talk about hepatitis B, there is a high risk of developing super infection hepatitis D, since hepatitis D remains infectious and can reactivate at very low titers that are not detected using modern analysis methods if HBsAg remains in the blood serum. The interaction of these viruses leads to accelerated progression of fibrosis and cirrhosis of the liver, which significantly increases the risk of developing acute liver failure against the background of chronic. In our case, a patient diagnosed with liver cirrhosis as a result of viral hepatitis B with delta agent, class C according to Child–Pugh–Turcotte, MELD-36 points, the patient developed a severe form of acute renal failure, which required emergency intervention, so he was not included in the waiting list for a transplant from a cadaveric donor. His wife became the donor, which is an example of living donation, which provides higher chances of successful recovery due to a shorter waiting time and a lower risk of graft rejection. Timely examination of the donor and recipient, as well as prompt liver transplantation, contributed to a favorable outcome of the disease.
31 December 2025 in BULLETIN OF SURGERY OF KAZAKHSTAN
Background: Small-for-size syndrome is one of the major causes of graft dysfunction after living donor liver transplantation in adults. Excessive portal inflow leading to sinusoidal hyperperfusion and impaired graft function is the primary mechanism of this complication. Effective prevention requires not only morphometric evaluation of the graft but also strict control of portal hemodynamics. Aim of the study is evaluate the effectiveness of graft inflow modulation and determine the prognostic significance of graft-to-recipient weight ratio, spleen-to-graft volume ratio, portal venous flow, and portal venous pressure. Materials and Methods: This study included adult patients who underwent living donor liver transplantation from 2011 to 2025. Portal hemodynamics was assessed intraoperatively. Graft inflow modulation was performed upon detection of portal hyperperfusion( p< 0.05). Results: Patients with small graft volume demonstrated elevated portal venous flow and pressure prior to intervention. Inflow modulation effectively reduced portal venous pressure to physiological levels and was associated with a lower incidence of small-for-size syndrome and reduced mortality. A spleen-to-graft volume ratio greater than 1.0 was linked to significant hyperperfusion and poorer clinical outcomes. Intraoperative modulation proved markedly more effective than delayed postoperative interventions, resulting in higher survival rates and an absence of severe graft dysfunction. Conclusion: Excessive portal inflow is the key determinant of graft dysfunction in living donor liver transplantation. Timely intraoperative modulation of portal blood flow improves hemodynamic stability and enhances survival. A combined assessment of morphometric and hemodynamic parameters enables optimal prevention of small-forsize syndrome and supports a personalized transplantation approach.
31 March 2026 in BULLETIN OF SURGERY OF KAZAKHSTAN
Background: Analysis of the potential of imaging methods in the differential diagnosis of renal cell carcinoma metastases to the pancreas is relevant. Materials and Methods: Sixteen patients with histologically confirmed renal cell carcinoma pancreatic metastases were treated at the A.V. Vishnevsky National Medical Research Center of Surgery from 2009 to 2025. Eleven (68.75%) patients had a history of nephrectomy within 4 to 16 years. Preoperative examination included ultrasound (n=16), MSCT with bolus contrast (n=16), MRI (n=10), and endoscopic ultrasound (n=6). Results: Solitary metastases were detected in 10 patients (62.5%). Tumors were located in the head of the pancreas in 5 patients, in the body - in 3 patients, and in the tail - in 2 patients. Multiple multifocal pancreatic lesions were in 6 patients (37.5%). The sizes of the secondary lesions ranged from 10 to 56 mm. The most informative diagnostic method for detecting focal pancreatic lesion is computed tomography with bolus contrast enhancement. Secondary tumors are most often detected subcapsularly, with an extraorgan component. The most accurate and effective texture parameters for preoperative prediction of RCC metastases were identified: CONVENTIONAL_HUmin; GLCM_Correlation; NGLDM_Coarseness; LCRA. The developed diagnostic model had a sensitivity and specificity of 95.8% and 62%, respectively, in the differential diagnosis of NETs and pancreatic renal cell carcinoma metastases, allowing its use for preoperative differential diagnosis based on MSCT scans with intravenous contrast.